Angiotensin 2 Receptor Blocker [EPC]

261728 reported adverse events

Drugs of this class: VALSARTAN VALSARTAN AND HYDROCHLOROTHIAZIDE IRBESARTAN TELMISARTAN IRBESARTAN AND HYDROCHLOROTHIAZIDE TELMISARTAN AND HYDROCHLOROTHIAZIDE AMLODIPINE AND VALSARTAN TELMISARTAN AND AMLODIPINE AMLODIPINE BESYLATE AND VALSARTAN AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE

These side effects are most commonly reported by patients taking drugs of the Angiotensin 2 Receptor Blocker [EPC] class:

# Side effect Count
0 DYSPNOEA 15406
1 DIZZINESS 15365
2 FATIGUE 15054
3 HYPOTENSION 13364
4 DEATH 11631
5 DRUG INEFFECTIVE 11550
6 COUGH 10120
7 NAUSEA 10050
8 MALAISE 9876
9 DIARRHOEA 9205
See all common reactions for Angiotensin 2 Receptor Blocker [EPC]

Drugs of the Angiotensin 2 Receptor Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THROAT CLEARING 961 0.4898
1 NEUROLOGIC NEGLECT SYNDROME 143 0.4294
2 EJECTION FRACTION ABNORMAL 359 0.4020
3 CAROTID ARTERY THROMBOSIS 145 0.2509
4 BLOOD PRESSURE INADEQUATELY CONTROLLED 1363 0.2491
5 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 200 0.2442
6 CARDIAC FAILURE CHRONIC 624 0.2051
7 CARDIAC DYSFUNCTION 352 0.1816
8 EJECTION FRACTION DECREASED 2120 0.1784
9 ADJUSTMENT DISORDER 144 0.1511
See all enriched reactions for Angiotensin 2 Receptor Blocker [EPC]